{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:30:35Z","timestamp":1782977435590,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aetiology of delirium is not known, but pre-existing cognitive impairment is a predisposing factor. Here we explore the associations between delirium and cerebrospinal fluid (CSF) levels of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs), proteins with important roles in both acute injury and chronic neurodegeneration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using a 13-plex Discovery Assay\u00ae, we quantified CSF levels of 9 MMPs and 4 TIMPs in 280 hip fracture patients (140 with delirium), 107 cognitively unimpaired individuals, and 111 patients with Alzheimer\u2019s disease dementia. The two delirium-free control groups without acute trauma were included to unravel the effects of acute trauma (hip fracture), dementia, and delirium.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Here we show that delirium is associated with higher levels of MMP-2, MMP-3, MMP-10, TIMP-1, and TIMP-2; a trend suggests lower levels of TIMP-4 are also associated with delirium. Most delirium patients had pre-existing dementia and low TIMP-4 is the only marker associated with delirium in adjusted analyses. MMP-2, MMP-12, and TIMP-1 levels are clearly higher in the hip fracture patients than in both control groups and several other MMP\/TIMPs are impacted by acute trauma or dementia status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Several CSF MMP\/TIMPs are significantly associated with delirium in hip fracture patients, but alterations in most of these MMP\/TIMPs could likely be explained by acute trauma and\/or pre-fracture dementia. Low levels of TIMP-4 appear to be directly associated with delirium, and the role of this marker in delirium pathophysiology should be further explored.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s43856-024-00558-z","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T05:02:34Z","timestamp":1719464554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Differences in metalloproteinases and their tissue inhibitors in the cerebrospinal fluid are associated with delirium"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7595-527X","authenticated-orcid":false,"given":"Mari","family":"Aksnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari Haavig","family":"Schibstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrukh Abbas","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn Erik","family":"Neerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Caplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvild","family":"Saltvedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5585-0446","authenticated-orcid":false,"given":"Rannveig S.","family":"Eldholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Myrstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0530-8771","authenticated-orcid":false,"given":"Trine Holt","family":"Edwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane-Victoria","family":"Idland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Thomas","family":"Pollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy Bj\u00f8rkholt","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torgeir Bruun","family":"Wyller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-4354","authenticated-orcid":false,"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9912-5174","authenticated-orcid":false,"given":"Emma","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0441-6700","authenticated-orcid":false,"given":"Leiv Otto","family":"Watne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"key":"558_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41572-020-00223-4","volume":"6","author":"JE Wilson","year":"2020","unstructured":"Wilson, J. E. et al. Delirium. Nat. Rev. Dis. Prim. 6, 90 (2020).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"558_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1001\/jama.2010.1013","volume":"304","author":"J Witlox","year":"2010","unstructured":"Witlox, J. et al. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA 304, 443\u2013451 (2010).","journal-title":"JAMA"},{"key":"558_CR3","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1001\/jamaneurol.2020.2273","volume":"77","author":"TE Goldberg","year":"2020","unstructured":"Goldberg, T. E. et al. Association of delirium with long-term cognitive decline: a meta-analysis. JAMA Neurol. 77, 1373\u20131381, (2020).","journal-title":"JAMA Neurol."},{"key":"558_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41582-022-00698-7","volume":"18","author":"TG Fong","year":"2022","unstructured":"Fong, T. G. & Inouye, S. K. The inter-relationship between delirium and dementia: the importance of delirium prevention. Nat. Rev. Neurol. 18, 579\u2013596 (2022).","journal-title":"Nat. Rev. Neurol."},{"key":"558_CR5","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41590-020-00812-1","volume":"21","author":"T Yang","year":"2020","unstructured":"Yang, T., Velagapudi, R. & Terrando, N. Neuroinflammation after surgery: from mechanisms to therapeutic targets. Nat. Immunol. 21, 1319\u20131326 (2020).","journal-title":"Nat. Immunol."},{"key":"558_CR6","doi-asserted-by":"crossref","unstructured":"Okada, Y. Proteinases and Matrix Degradation. In Kelley and Firestein\u2019s Textbook of Rheumatology, 10th edn Vol. 1 (eds Gary S. Firestein et al.) 106\u2212125 (Elsevier, 2017).","DOI":"10.1016\/B978-0-323-31696-5.00008-5"},{"key":"558_CR7","doi-asserted-by":"publisher","first-page":"15337","DOI":"10.1523\/JNEUROSCI.3467-10.2010","volume":"30","author":"S Rivera","year":"2010","unstructured":"Rivera, S., Khrestchatisky, M., Kaczmarek, L., Rosenberg, G. A. & Jaworski, D. M. Metzincin Proteases and their inhibitors: foes or friends in nervous system physiology? J. Neurosci. 30, 15337\u201315357 (2010).","journal-title":"J. Neurosci."},{"key":"558_CR8","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrn1807","volume":"6","author":"VW Yong","year":"2005","unstructured":"Yong, V. W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat. Rev. Neurosci. 6, 931\u2013944 (2005).","journal-title":"Nat. Rev. Neurosci."},{"key":"558_CR9","doi-asserted-by":"publisher","first-page":"30375","DOI":"10.1074\/jbc.271.48.30375","volume":"271","author":"J Greene","year":"1996","unstructured":"Greene, J. et al. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem. 271, 30375\u201330380 (1996).","journal-title":"J. Biol. Chem."},{"key":"558_CR10","doi-asserted-by":"publisher","first-page":"620581","DOI":"10.1155\/2015\/620581","volume":"2015","author":"M Brkic","year":"2015","unstructured":"Brkic, M., Balusu, S., Libert, C. & Vandenbroucke, R. E. Friends or Foes: Matrix Metalloproteinases and their multifaceted roles in neurodegenerative diseases. Mediators Inflamm. 2015, 620581 (2015).","journal-title":"Mediators Inflamm."},{"key":"558_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.brainres.2015.04.024","volume":"1623","author":"Y Yang","year":"2015","unstructured":"Yang, Y. & Rosenberg, G. A. Matrix metalloproteinases as therapeutic targets for stroke. Brain Res. 1623, 30\u201338 (2015).","journal-title":"Brain Res."},{"key":"558_CR12","doi-asserted-by":"publisher","first-page":"51817","DOI":"10.18632\/oncotarget.15545","volume":"8","author":"J Bi","year":"2017","unstructured":"Bi, J., Shan, W., Luo, A. & Zuo, Z. Critical role of matrix metallopeptidase 9 in postoperative cognitive dysfunction and age-dependent cognitive decline. Oncotarget 8, 51817\u201351829 (2017).","journal-title":"Oncotarget"},{"key":"558_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fncel.2016.00105","volume":"10","author":"Z Li","year":"2016","unstructured":"Li, Z. et al. Surgery-induced Hippocampal Angiotensin II elevation causes blood-brain barrier disruption via MMP\/TIMP in aged rats. Front. Cell. Neurosci. 10, 105 (2016).","journal-title":"Front. Cell. Neurosci."},{"key":"558_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1374-3","volume":"15","author":"P Ni","year":"2018","unstructured":"Ni, P. et al. IL-17A contributes to perioperative neurocognitive disorders through blood-brain barrier disruption in aged mice. J. Neuroinflamm. 15, 332 (2018).","journal-title":"J. Neuroinflamm."},{"key":"558_CR15","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1212\/WNL.0000000000004329","volume":"89","author":"M Cavallari","year":"2017","unstructured":"Cavallari, M. et al. Longitudinal diffusion changes following postoperative delirium in older people without dementia. Neurology 89, 1020\u20131027 (2017).","journal-title":"Neurology"},{"key":"558_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/brain\/awac328","volume":"146","author":"S Abu-Rumeileh","year":"2023","unstructured":"Abu-Rumeileh, S. et al. The multifaceted role of neurofilament light chain protein in non-primary neurological diseases. Brain 146, 421\u2013437 (2023).","journal-title":"Brain"},{"key":"558_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1159\/000494754","volume":"46","author":"NB Halaas","year":"2018","unstructured":"Halaas, N. B. et al. Neurofilament light in serum and cerebrospinal fluid of hip fracture patients with Delirium. Dement. Geriatr. Cogn. Disord. 46, 346\u2013357 (2018).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"558_CR18","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s00134-012-2678-x","volume":"38","author":"TD Girard","year":"2012","unstructured":"Girard, T. D. et al. Associations of markers of inflammation and coagulation with delirium during critical illness. Intensive Care Med. 38, 1965\u20131973 (2012).","journal-title":"Intensive Care Med."},{"key":"558_CR19","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1164\/rccm.2107138","volume":"166","author":"CN Sessler","year":"2002","unstructured":"Sessler, C. N. et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am. J. Respir. Crit. Care Med. 166, 1338\u20131344 (2002).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"558_CR20","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.jagp.2013.05.003","volume":"21","author":"Z Tieges","year":"2013","unstructured":"Tieges, Z., McGrath, A., Hall, R. J. & Maclullich, A. M. Abnormal level of arousal as a predictor of delirium and inattention: an exploratory study. Am. J. Geriatr. Psychiatry 21, 1244\u20131253 (2013).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"558_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bpa.2012.07.002","volume":"26","author":"RJ Hall","year":"2012","unstructured":"Hall, R. J., Meagher, D. J. & MacLullich, A. M. Delirium detection and monitoring outside the ICU. Best. Pract. Res. Clin. Anaesthesiol. 26, 367\u2013383 (2012).","journal-title":"Best. Pract. Res. Clin. Anaesthesiol."},{"key":"558_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12877-015-0006-3","volume":"15","author":"BE Neerland","year":"2015","unstructured":"Neerland, B. E. et al. The protocol of the Oslo Study of Clonidine in Elderly Patients with Delirium; LUCID: a randomised placebo-controlled trial. BMC Geriatr. 15, 7 (2015).","journal-title":"BMC Geriatr."},{"key":"558_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1017\/S1041610204000390","volume":"16","author":"AF Jorm","year":"2004","unstructured":"Jorm, A. F. The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review. Int. Psychogeriatr. 16, 275\u2013293 (2004).","journal-title":"Int. Psychogeriatr."},{"key":"558_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/anae.14569","volume":"74","author":"D Mayhew","year":"2019","unstructured":"Mayhew, D., Mendonca, V. & Murthy, B. V. S. A review of ASA physical status\u2014historical perspectives and modern developments. Anaesthesia 74, 373\u2013379 (2019).","journal-title":"Anaesthesia"},{"key":"558_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2020.04.002","volume":"93","author":"AV Idland","year":"2020","unstructured":"Idland, A. V. et al. Biomarker profiling beyond amyloid and tau: cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults. Neurobiol. Aging 93, 1\u201315 (2020).","journal-title":"Neurobiol. Aging"},{"key":"558_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72878-8","volume":"10","author":"A-B Knapskog","year":"2020","unstructured":"Knapskog, A.-B. et al. Cerebrospinal fluid sTREM2 in Alzheimer\u2019s disease: comparisons between clinical presentation and AT classification. Sci. Rep. 10, 15886 (2020).","journal-title":"Sci. Rep."},{"key":"558_CR27","doi-asserted-by":"publisher","first-page":"e058810","DOI":"10.1136\/bmjopen-2021-058810","volume":"12","author":"IT Medb\u00f8en","year":"2022","unstructured":"Medb\u00f8en, I. T. et al. Cohort profile: the Norwegian Registry of Persons Assessed for Cognitive Symptoms (NorCog)\u2014a national research and quality registry with a biomaterial collection. BMJ Open 12, e058810 (2022).","journal-title":"BMJ Open"},{"key":"558_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7, 263\u2013269 (2011).","journal-title":"Alzheimers Dement"},{"key":"558_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr.","year":"2018","unstructured":"Jack, C. R. Jr. et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement"},{"key":"558_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/glia.10108","volume":"39","author":"GA Rosenberg","year":"2002","unstructured":"Rosenberg, G. A. Matrix metalloproteinases in neuroinflammation. Glia 39, 279\u2013291 (2002).","journal-title":"Glia"},{"key":"558_CR31","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1002\/gps.4720","volume":"33","author":"RJ Hall","year":"2018","unstructured":"Hall, R. J. et al. CSF biomarkers in delirium: a systematic review. Int. J. Geriatr. Psychiatry 33, 1479\u20131500 (2018).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"558_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/wound.2014.0581","volume":"4","author":"MP Caley","year":"2015","unstructured":"Caley, M. P., Martins, V. L. & O\u2019Toole, E. A. Metalloproteinases and Wound Healing. Adv. Wound Care 4, 225\u2013234 (2015).","journal-title":"Adv. Wound Care"},{"key":"558_CR33","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1183\/09031936.00032111","volume":"38","author":"A Davey","year":"2011","unstructured":"Davey, A., McAuley, D. F. & O\u2019Kane, C. M. Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair. Eur. Respir. J. 38, 959\u2013970 (2011).","journal-title":"Eur. Respir. J."},{"key":"558_CR34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.bjp.0707344","volume":"152","author":"AK Chow","year":"2007","unstructured":"Chow, A. K., Cena, J. & Schulz, R. Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature. Br. J. Pharmacol. 152, 189\u2013205 (2007).","journal-title":"Br. J. Pharmacol."},{"key":"558_CR35","doi-asserted-by":"publisher","first-page":"10107","DOI":"10.1523\/JNEUROSCI.23-31-10107.2003","volume":"23","author":"JE Wells","year":"2003","unstructured":"Wells, J. E. et al. An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J. Neurosci. 23, 10107\u201310115 (2003).","journal-title":"J. Neurosci."},{"key":"558_CR36","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/ana.10553","volume":"53","author":"C Power","year":"2003","unstructured":"Power, C. et al. Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann. Neurol. 53, 731\u2013742 (2003).","journal-title":"Ann. Neurol."},{"key":"558_CR37","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1093\/brain\/awac024","volume":"145","author":"PV Martino Adami","year":"2022","unstructured":"Martino Adami, P. V. et al. Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer\u2019s type. Brain 145, 2507\u20132517 (2022).","journal-title":"Brain"},{"key":"558_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-020-1608-8","volume":"20","author":"A Santaella","year":"2020","unstructured":"Santaella, A. et al. Inflammation biomarker discovery in Parkinson\u2019s disease and atypical parkinsonisms. BMC Neurol. 20, 26 (2020).","journal-title":"BMC Neurol."},{"key":"558_CR39","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neulet.2009.09.043","volume":"466","author":"R Mlekusch","year":"2009","unstructured":"Mlekusch, R. & Humpel, C. Matrix metalloproteinases-2 and \u22123 are reduced in cerebrospinal fluid with low beta-amyloid1\u201342 levels. Neurosci. Lett. 466, 135\u2013138 (2009).","journal-title":"Neurosci. Lett."},{"key":"558_CR40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/alzrt44","volume":"2","author":"E Stomrud","year":"2010","unstructured":"Stomrud, E., Bj\u00f6rkqvist, M., Janciauskiene, S., Minthon, L. & Hansson, O. Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer\u2019s disease. Alzheimers Res. Ther. 2, 20 (2010).","journal-title":"Alzheimers Res. Ther."},{"key":"558_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13293-023-00514-x","volume":"14","author":"M Aksnes","year":"2023","unstructured":"Aksnes, M. et al. Sex-specific associations of matrix metalloproteinases in Alzheimer\u2019s disease. Biol. Sex. Differ. 14, 35 (2023).","journal-title":"Biol. Sex. Differ."},{"key":"558_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1476-4598-7-85","volume":"7","author":"J Melendez-Zajgla","year":"2008","unstructured":"Melendez-Zajgla, J., Del Pozo, L., Ceballos, G. & Maldonado, V. Tissue inhibitor of metalloproteinases-4. The road less traveled.Mol. Cancer 7, 85 (2008).","journal-title":"Mol. Cancer"},{"key":"558_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0014-5793(96)01474-3","volume":"401","author":"KJ Leco","year":"1997","unstructured":"Leco, K. J. et al. Murine tissue inhibitor of metalloproteinases-4 (Timp-4): cDNA isolation and expression in adult mouse tissues. FEBS Lett. 401, 213\u2013217 (1997).","journal-title":"FEBS Lett."},{"key":"558_CR44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4269\/ajtmh.2008.78.20","volume":"78","author":"H-C Tsai","year":"2008","unstructured":"Tsai, H.-C. et al. Association of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinase-4 in cerebrospinal fluid with blood-brain barrier dysfunction in patients with eosinophilic meningitis caused by Angiostrongylus cantonensis. Am. J. Trop. Med. Hyg. 78, 20\u201327 (2008).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"558_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cyto.2011.02.007","volume":"54","author":"H-C Tsai","year":"2011","unstructured":"Tsai, H.-C. et al. Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with HIV-1 infection and syphilis or neurosyphilis. Cytokine 54, 109\u2013116 (2011).","journal-title":"Cytokine"},{"key":"558_CR46","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1007\/s11064-010-0226-z","volume":"35","author":"M Killer","year":"2010","unstructured":"Killer, M. et al. Cytokine and growth factor concentration in cerebrospinal fluid from patients with hydrocephalus following endovascular embolization of unruptured aneurysms in comparison with other types of Hydrocephalus. Neurochem. Res. 35, 1652\u20131658 (2010).","journal-title":"Neurochem. Res."},{"key":"558_CR47","doi-asserted-by":"crossref","unstructured":"Fatehi Hassanabad, A. et al. Comprehensive characterization of the postoperative pericardial inflammatory response: Potential implications for clinical outcomes. JTCVS Open 12, 118\u2013136 (2022).","DOI":"10.1016\/j.xjon.2022.09.003"},{"key":"558_CR48","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1097\/SLA.0000000000002684","volume":"269","author":"EL Cunningham","year":"2019","unstructured":"Cunningham, E. L. et al. CSF Beta-amyloid 1-42 concentration predicts Delirium following elective arthroplasty surgery in an observational cohort study. Ann. Surg. 269, 1200\u20131205 (2019).","journal-title":"Ann. Surg."},{"key":"558_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cca.2008.02.023","volume":"392","author":"A Sulik","year":"2008","unstructured":"Sulik, A., Wojtkowska, M. & Oldak, E. Preanalytical factors affecting the stability of matrix metalloproteinase-2 concentrations in cerebrospinal fluid. Clin. Chim. Acta 392, 73\u201375 (2008).","journal-title":"Clin. Chim. Acta"},{"key":"558_CR50","doi-asserted-by":"crossref","unstructured":"Watne, L. O. et al. Cerebrospinal fluid quinolinic acid is strongly associated with delirium and mortality in hip fracture patients. J. Clin. Invest., 133, e163472 (2022).","DOI":"10.1172\/JCI163472"},{"key":"558_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0022-510X(02)00398-2","volume":"207","author":"S Lorenzl","year":"2003","unstructured":"Lorenzl, S. et al. Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases. J. Neurol. Sci. 207, 71\u201376 (2003).","journal-title":"J. Neurol. Sci."},{"key":"558_CR52","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1007\/s00018-019-03178-2","volume":"76","author":"S Rivera","year":"2019","unstructured":"Rivera, S., Garc\u00eda-Gonz\u00e1lez, L., Khrestchatisky, M. & Baranger, K. Metalloproteinases and their tissue inhibitors in Alzheimer\u2019s disease and other neurodegenerative disorders. Cell. Mol. Life Sci. 76, 3167\u20133191 (2019).","journal-title":"Cell. Mol. Life Sci."},{"key":"558_CR53","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/ageing\/afw065","volume":"45","author":"TA Jackson","year":"2016","unstructured":"Jackson, T. A., MacLullich, A. M., Gladman, J. R., Lord, J. M. & Sheehan, B. Diagnostic test accuracy of informant-based tools to diagnose dementia in older hospital patients with delirium: a prospective cohort study. Age Ageing 45, 505\u2013511 (2016).","journal-title":"Age Ageing"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00558-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00558-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00558-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T06:09:37Z","timestamp":1719468577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00558-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["558"],"URL":"https:\/\/doi.org\/10.1038\/s43856-024-00558-z","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,27]]},"assertion":[{"value":"9 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: KP reports work with Novo Nordisk NN6535-4730 trial outside the submitted work. HZ has served at scientific advisory boards and\/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). All other authors explicitly report no disclosures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. All data and materials were collected after informed written consent from the patient, or from the next of kin if patients were unable to consent due to cognitive impairment; next of kin have the authority to grant consent in Norway under the Act on Medical and Health Research (ACT 2008-06-20). The Regional Committee for Ethics in Medical Research in Norway has approved the multi-centre study from which hip fracture patients were included (REC Central, #19337); the Cognorm study (REC South East, #12064); and the study of inflammatory biomarkers in the NorCog material (REC South East #6897). The ethical approval encompasses the current study, including analysis of MMP and TIMP biomarkers and comparisons across cohorts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"124"}}